Journal of the American Pharmacists Association : JAPhA

Guidelines for using incretin-based treatments to manage weight

Updated

Abstract

The use of incretin-based therapies for weight management has expanded rapidly but presents several challenges.

  • Inconsistent prescribing practices are common in real-world applications of incretin-based therapies.
  • Access barriers may limit patient utilization of these treatments.
  • Limited long-term safety data raises concerns about the ongoing use of these therapies.
  • Low treatment persistence is observed among patients using incretin-based therapies.
  • Equity and financial sustainability issues are significant considerations in the adoption of these therapies.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free